# Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)

> **NCT07177560** · — · COMPLETED · sponsor: **Gazi University** · enrollment: 151 (actual)

## Conditions studied

- Colorectal Cancer
- Gastric Cancer (GC)
- Capecitabine
- Hand Foot Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07177560
- **Lead sponsor:** Gazi University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-30
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-02-28
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07177560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07177560, "Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07177560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*